As President of the Ludwig Institute for Cancer Research, I am responsible for the Institute’s scientific, clinical and business operations. My background is in technology and business development. Establishing collaborative partnerships with other not-for-profits and licensing relationships with commercial partners is a critical process in moving Ludwig technologies into the clinic where they may benefit cancer patients. I have completed numerous partnering transactions with biopharma companies, including Ludwig start-up biotechnology companies established to develop and commercialize Ludwig scientific discoveries and technologies. I received a PhD in Immunology from University College London and completed further cancer immunology research at the University of Virginia and the University of Oxford.